PG PROCTER & GAMBLE Co
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · NYSE · SEC CIK 80424 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY3.5%
TTM net income YoY-4.4%
TTM EPS YoY-3.1%
Revenue 3-yr CAGR1.8%
Net income 3-yr CAGR1.7%
Margins
Gross margin49.8%
Operating margin22.6%
Net margin18.2%
FCF margin17.4%
EBITDA margin26.2%
Returns
ROE29.6%
ROA12.3%
ROIC (approx.)20.0%
Asset turnover0.67x
Leverage & solvency
Liabilities / assets58.4%
Debt / equity0.71x
Current ratio0.72x
Interest coverage21.98x
Cash quality & payout
Operating cash flow / net income1.24x
Accruals ratio-3.0%
Payout ratio64.2%
Capex / revenue5.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q12026-09-30 | 2026Q4*2026-06-30 | 2026Q32026-03-31 | 2026Q22025-12-31 | 2026Q12025-09-30 | 2025Q4*2025-06-30 | 2025Q32025-03-31 | 2025Q22024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $23.28B | $21.20B | $21.23B | $22.21B | $22.39B | $20.89B | $19.78B | $21.88B |
| Cost of revenue | $11.68B | $10.92B | $10.72B | $10.83B | $10.89B | $10.63B | $9.69B | $10.42B |
| Gross profit | $11.60B | $10.28B | $10.51B | $11.37B | $11.50B | $10.26B | $10.08B | $11.46B |
| SG&A expense | $5.66B | $6.33B | $5.94B | $6.01B | $5.64B | $5.90B | $5.52B | $5.72B |
| Operating income | $5.94B | $3.95B | $4.58B | $5.37B | $5.86B | $4.36B | $4.56B | $5.74B |
| Interest expense | $223.00M | $236.00M | $223.00M | $220.00M | $197.00M | $212.00M | $217.00M | $240.00M |
| Income tax | $1.27B | $852.00M | $1.04B | $1.09B | $1.25B | $895.00M | $868.00M | $1.19B |
| Net income | $4.73B | $3.04B | $3.93B | $4.32B | $4.75B | $3.62B | $3.77B | $4.63B |
| EBITDA | $6.75B | $4.76B | $5.36B | $6.17B | $6.62B | $5.08B | $5.25B | $6.45B |
| EPS (basic) | 2.00 | — | 1.66 | 1.82 | 2.00 | — | 1.58 | 1.94 |
| EPS (diluted) | 1.97 | — | 1.63 | 1.78 | 1.95 | — | 1.54 | 1.88 |
| Dividends declared per share | 1.09 | 1.09 | 1.06 | 1.06 | 1.06 | 1.06 | 1.01 | 1.01 |
| Weighted avg. shares (diluted) | 2.41B | — | 2.42B | 2.42B | 2.44B | — | 2.45B | 2.46B |
| Balance sheet | ||||||||
| Cash & equivalents | $15.37B | $9.94B | $12.31B | $10.82B | $11.17B | $9.56B | $9.12B | $10.23B |
| Receivables | $6.62B | $6.06B | $6.32B | $6.28B | $6.49B | $6.18B | $6.14B | $6.23B |
| Inventory | $8.48B | $8.17B | $7.85B | $7.82B | $7.85B | $7.55B | $7.40B | $7.02B |
| Current assets | $32.51B | $26.21B | $27.99B | $26.59B | $27.12B | $25.39B | $24.43B | $25.64B |
| PP&E, net | $25.52B | $25.36B | $24.57B | $24.49B | $24.12B | $23.90B | $22.73B | $22.07B |
| Goodwill | $41.20B | $41.28B | $41.36B | $41.66B | $41.64B | $41.65B | $40.48B | $39.90B |
| Intangibles | $21.36B | $21.44B | $21.53B | $21.74B | $21.82B | $21.91B | $21.84B | $21.83B |
| Total assets | $133.13B | $126.52B | $128.38B | $127.29B | $127.60B | $125.23B | $122.98B | $122.64B |
| Current liabilities | $45.00B | $38.69B | $38.23B | $36.70B | $37.99B | $36.06B | $34.25B | $33.80B |
| Short-term debt | $17.03B | $11.30B | $13.17B | $11.06B | $11.63B | $9.51B | $9.89B | $9.42B |
| Long-term debt | $21.90B | $22.84B | $23.85B | $25.58B | $24.32B | $25.00B | $24.25B | $25.26B |
| Total debt | $38.92B | $34.14B | $37.03B | $36.64B | $35.95B | $34.51B | $34.14B | $34.69B |
| Total liabilities | $77.80B | $72.21B | $73.65B | $73.97B | $74.05B | $72.95B | $70.44B | $71.19B |
| Shareholders' equity | $55.10B | $54.08B | $54.51B | $53.04B | $53.27B | $52.01B | $52.27B | $51.17B |
| Net debt | $23.56B | $24.20B | $24.72B | $25.81B | $24.77B | $24.95B | $25.02B | $24.46B |
| Cash flow statement | ||||||||
| Operating cash flow | $5.77B | $5.13B | $4.04B | $4.97B | $5.41B | $4.99B | $3.71B | $4.83B |
| Capital expenditure | $1.37B | $1.02B | $1.02B | $1.17B | $1.20B | $996.00M | $859.00M | $925.00M |
| Free cash flow | $4.40B | $4.11B | $3.03B | $3.81B | $4.21B | $3.99B | $2.85B | $3.90B |
| Investing cash flow | -$1.46B | -$1.20B | -$665.00M | -$1.23B | -$1.53B | -$1.06B | -$726.00M | -$921.00M |
| Financing cash flow | $1.14B | -$6.31B | -$1.83B | -$4.09B | -$2.24B | -$3.62B | -$4.21B | -$5.57B |
| Depreciation & amortization | $810.00M | $812.00M | $785.00M | $803.00M | $761.00M | $723.00M | $690.00M | $706.00M |
| Stock-based compensation | $98.00M | $130.00M | $132.00M | $140.00M | $121.00M | $112.00M | $123.00M | $136.00M |
| Dividends paid | $2.60B | $2.61B | $2.53B | $2.54B | $2.55B | $2.55B | $2.43B | $2.44B |
| Share buybacks | $1.25B | $875.00M | $625.00M | $2.28B | $1.25B | $700.00M | $1.35B | $2.51B |
Free plan shows the latest 8 periods; Pro shows all 73 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.